Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Diego de Miguel Samaniego

Professor and Researcher

Universidad de Zaragoza

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Biochemistry Biochemistry professors in Spain

Articles (12)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (12)

Nerea Irigoyen

University of Cambridge

UNITED KINGDOM

View details

Juan Martínez Olivan

Chief Scientific Officer

CERTEST BIOTEC

SPAIN

View details

Antonio Alcami

Research Professor

Consejo Superior de Investigaciones Cientificas

SPAIN

View details

Johannes Brägelmann

Professor

University Hospital Bonn

GERMANY

View details

Nieves Peltzer

Professor

University of Stuttgart

GERMANY

View details

Henning Walczak

Alexander-von-Humboldt Professor of Biochemistry

University of Cologne

GERMANY

View details

Michael Bergmann

since 1994 Principal Investigator; 2010-20: Head of the Surgical Research Lab of the former Clinic of Surgery

Medical University of Vienna

AUSTRIA

View details

Rebeca Sanz-Pamplona

Instituto de Investigación Sanitaria Aragón

SPAIN

View details

Julian Pardo

Professor

Universidad de Zaragoza

SPAIN

View details

Alessandro Annibaldi

Lecturer

Barts Cancer Institute

UNITED KINGDOM

View details

Alberto Anel

Professor

Universidad de Zaragoza

SPAIN

View details

Joaquín Marco-Brualla

Associate Professor

Universidad CEU San Pablo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Diego de Miguel Samaniego

Research Interests

Explore related searches

Articles (12)

Lysine-11 ubiquitination drives type-I/III interferon induction by cGAS–STING and Toll-like receptors 3 and 4

Preserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25 °C

A Complete Approach for circRNA Therapeutics from Purification to Lyophilized Delivery Using Novel Ionizable Lipids

Multicomponent thiolactone-based ionizable lipid screening platform for efficient and tunable mRNA delivery to the lungs

Predictive Lung- and Spleen-Targeted mRNA Delivery with Biodegradable Ionizable Lipids in Four-Component LNPs

Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trial.

Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality

Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs

LUBAC is required for RIG-I sensing of RNA viruses

LUBAC enables tumor-promoting LTβ receptor signaling by activating canonical NF-κB

DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAIL

Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair

Collaborators (12)

Nerea Irigoyen

Juan Martínez Olivan

Antonio Alcami

Johannes Brägelmann

Nieves Peltzer

Henning Walczak

Michael Bergmann

Rebeca Sanz-Pamplona

Julian Pardo

Alessandro Annibaldi

Alberto Anel

Joaquín Marco-Brualla

Make your next move.